Drug Profile
Quadrivalent seasonal influenza vaccine - Clover Biopharmaceuticals
Alternative Names: Hemagglutinin (HA)-Trimer vaccine; Pandemic Flu Vaccine - Clover BiopharmaceuticalsLatest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Clover Biopharmaceuticals; GenHunter Corporation
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for preclinical development in Influenza-virus-infections in China
- 28 Dec 2017 Clover Biopharmaceuticals in-licenses Trimer-Tag© technology from GenHunter Corporation worldwide (Clover Biopharmaceuticals website, December 2017)
- 28 Dec 2017 Quadrivalent seasonal influenza vaccine - Clover Biopharmaceuticals is available for licensing as of 28 Dec 2017. http://www.cloverbiopharma.com/index.php?m=content&c=index&a=lists&catid=44